Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.

Fiche publication


Date publication

septembre 2022

Journal

Archives of cardiovascular diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves


Tous les auteurs :
Tea V, Morelle JF, Gallet R, Cayla G, Lemesle G, Lhermusier T, Dillinger JG, Ducrocq G, Angouvant D, Cottin Y, Chamandi C, le Bras A, Steg PG, Montalescot G, Nelson AC, Simon T, Chatellier G, Danchin N, Puymirat E,

Résumé

In patients with ST-segment elevation myocardial infarction and multivessel disease, percutaneous coronary intervention for non-culprit lesions is superior to treatment of the culprit lesion alone. The optimal timing for non-infarct-related artery revascularization - immediate versus staged - has not been investigated adequately.

Mots clés

Acute myocardial infarction, Fractional flow reserve, Multivessel disease

Référence

Arch Cardiovasc Dis. 2022 09 2;: